These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26468283)

  • 41. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
    Nan R; Gor J; Perkins SJ
    J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification, quantification, and functional analysis of Complement Factor H.
    Yu BB; Moffatt BE; Fedorova M; Villiers CG; Arnold JN; Du E; Swinkels A; Li MC; Ryan A; Sim RB
    Methods Mol Biol; 2014; 1100():207-23. PubMed ID: 24218262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein E.
    Charpentier D; Tremblay C; Rassart E; Rhainds D; Auger A; Milne RW; Brissette L
    Biochemistry; 2000 Dec; 39(51):16084-91. PubMed ID: 11123936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.
    Zhao W; Du F; Zhang M; Sun S; Yu H; Fan D
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1468-76. PubMed ID: 22087021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
    Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
    Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
    Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1.
    Hovis KM; Jones JP; Sadlon T; Raval G; Gordon DL; Marconi RT
    Infect Immun; 2006 Apr; 74(4):2007-14. PubMed ID: 16552029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands.
    Fisher C; Abdul-Aziz D; Blacklow SC
    Biochemistry; 2004 Feb; 43(4):1037-44. PubMed ID: 14744149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A synthetic protein as efficient multitarget regulator against complement over-activation.
    Ruiz-Molina N; Parsons J; Müller M; Hoernstein SNW; Bohlender LL; Pumple S; Zipfel PF; Häffner K; Reski R; Decker EL
    Commun Biol; 2022 Feb; 5(1):152. PubMed ID: 35194132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein.
    Beernink PT; Giuntini S; Costa I; Lucas AH; Granoff DM
    mBio; 2015 Jun; 6(3):e00842. PubMed ID: 26106082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement Regulation.
    Harder MJ; Anliker M; Höchsmann B; Simmet T; Huber-Lang M; Schrezenmeier H; Ricklin D; Lambris JD; Barlow PN; Schmidt CQ
    J Immunol; 2016 Jan; 196(2):866-76. PubMed ID: 26643478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH).
    Morgan HP; Mertens HD; Guariento M; Schmidt CQ; Soares DC; Svergun DI; Herbert AP; Barlow PN; Hannan JP
    PLoS One; 2012; 7(2):e32187. PubMed ID: 22389686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
    J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The aminoterminal 1-185 domain of human apolipoprotein E suffices for the de novo biogenesis of apoE-containing HDL-like particles in apoA-I deficient mice.
    Petropoulou PA; Gantz DL; Wang Y; Rensen PC; Kypreos KE
    Atherosclerosis; 2011 Nov; 219(1):116-23. PubMed ID: 21802082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.
    Laudanski K; Okeke T; Siddiq K; Hajj J; Restrepo M; Gullipalli D; Song WC
    Sci Rep; 2022 Aug; 12(1):13658. PubMed ID: 35953544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc.
    Areschoug T; Stålhammar-Carlemalm M; Karlsson I; Lindahl G
    J Biol Chem; 2002 Apr; 277(15):12642-8. PubMed ID: 11812795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of biologically active complement factor H in therapeutically useful quantities.
    Schmidt CQ; Slingsby FC; Richards A; Barlow PN
    Protein Expr Purif; 2011 Apr; 76(2):254-63. PubMed ID: 21146613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of human complement factor H binding to asexual malaria blood stages by an enzyme-linked immunosorbent assay.
    Simon N; Friedrich O; Kappes B
    Vaccine; 2018 Mar; 36(12):1545-1547. PubMed ID: 29449098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniae.
    Achila D; Liu A; Banerjee R; Li Y; Martinez-Hackert E; Zhang JR; Yan H
    Biochem J; 2015 Jan; 465(2):325-35. PubMed ID: 25330773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.